Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones

Yesterday

DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 4.38% to $10.60 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.32% to 26,421.41 and Dow Jones Industrial Average falling 1.18% to 52,786.07.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 48.47% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.84% to $5.33, Fortress Biotech Inc. (FBIO) fell 0.37% to $2.71, and Viking Therapeutics Inc. (VKTX) fell 3.41% to $33.68.

Trading volume (915,184) eclipsed its 50-day average volume of 453,028.

Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/news/2666701133"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2666701133\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2666701133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 05:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2666701133","market":"fut","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slipped 4.38% to $10.60 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.32% to 26,421.41 and Dow Jones Industrial Average  falling 1.18% to 52,786.07. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 48.47% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 1.84% to $5.33, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 0.37% to $2.71, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) fell 3.41% to $33.68. \n</p>\n<p>\n     Trading volume (915,184) eclipsed its 50-day average volume of 453,028. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-09-09 05:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> slipped 4.38% to $10.60 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.32% to 26,421.41 and Dow Jones Industrial Average  falling 1.18% to 52,786.07. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 48.47% below its 52-week high of $20.56, which the company achieved on October 20th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 1.84% to $5.33, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 0.37% to $2.71, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) fell 3.41% to $33.68. \n</p>\n<p>\n     Trading volume (915,184) eclipsed its 50-day average volume of 453,028. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2666701133","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2666701133","pubTimestamp":1788902460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 4.38% to $10.60 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.32% to 26,421.41 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 48.47% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 1.84% to $5.33, Fortress Biotech Inc.  fell 0.37% to $2.71, and Viking Therapeutics Inc.  fell 3.41% to $33.68.Trading volume  eclipsed its 50-day average volume of 453,028.Data source: Dow Jones Market Data, FactSet. Data compiled Se","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"与竞争对手相比，Corbus Pharmaceuticals Holdings Inc. 股票周二表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1.5},"content_text":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 4.38% to $10.60 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.32% to 26,421.41 and Dow Jones Industrial Average  falling 1.18% to 52,786.07. \n\n\n     This was the stock's third consecutive day of losses. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed 48.47% below its 52-week high of $20.56, which the company achieved on October 20th. \n\n\n     The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.84% to $5.33, Fortress Biotech Inc. (FBIO) fell 0.37% to $2.71, and Viking Therapeutics Inc. (VKTX) fell 3.41% to $33.68. \n\n\n     Trading volume (915,184) eclipsed its 50-day average volume of 453,028. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}